Streetbeat News

KERN

Akerna Corp

Employees

93

Industry

Data Processing, Hosting, and Related Services

mj freeway® is the industry-leading software, consulting, and data solution for cannabis businesses, processing $5b in cannabis sales transactions and serving clients in every regulated market in the united states, canada, europe, and australia. founded in 2010 and designed and built specifically for cannabis businesses, mj freeway's technology includes a patented seed to sale supply chain erp platform which leverages sophisticated business intelligence insights. mj freeway's leaf data systems technology solution enables governments to track cannabis, prevent diversion and ensure patient, public, and product safety. mj freeway also offers a complete suite of consulting services for cannabis businesses. for more information, call 888-932-6537 or visit mjfreeway.com.

Open

0.25

Mkt cap

162K

Volume

1.2M

High

0.32

P/E Ratio

-0.01

52-wk high

20.40

Low

0.25

Div yield

N/A

52-wk low

0.25

In Wednesday's after-market session, several IT stocks saw significant movements. CISO Global's shares surged by 14.4% following their Q3 earnings report two days ago. Synchronoss Technologies, Viant Technology, Movano, Expensify, and Marin Software also experienced gains. Conversely, Cisco Systems and Palo Alto Networks saw their shares drop by 9.4% and 8.74%, respectively, after their Q1 earnings were released. Other losers included Aurora Mobile, ReAlpha Tech Corp, Akerna, and Pixelworks.

Portfolio Pulse from Benzinga Insights

November 15, 2023 | 9:30 pm

In Tuesday's after-market session, ReAlpha Tech Corp (AIRE) saw a significant increase of 85.9% in stock price, while HeartCore Enterprises (HTCR) experienced the largest drop of 12.1%. Other notable gainers included Cyngn (CYN), Akerna (KERN), Infobird Co (IFBD), GSI Technology (GSIT), and UTime (WTO). On the losing side were Peraso (PRSO), SEALSQ (LAES), WiSA Technologies (WISA), OMNIQ (OMQS), and Aurora Mobile (JG). The movements were attributed to trading volumes and recent Q3 earnings reports.

Portfolio Pulse from Benzinga Insights

November 14, 2023 | 9:31 pm

In Monday's after-market session, ReAlpha Tech Corp (AIRE) saw a significant increase of 52.1%, while HeartCore Enterprises (HTCR) experienced the largest drop of 9.8%. Other notable gainers included MicroCloud Hologram (HOLO), Cyngn (CYN), Akerna (KERN), Infobird Co (IFBD), and GSI Technology (GSIT). On the losing side were Peraso (PRSO), SEALSQ (LAES), OMNIQ (OMQS), Porch Group (PRCH), and AEye (LIDR), with their stocks declining after their Q3 earnings reports were released.

Portfolio Pulse from Benzinga Insights

November 13, 2023 | 9:30 pm

Republican presidential candidate Vivek Ramaswamy plans to remove federal restrictions on marijuana and psychedelics for veterans with PTSD if elected. He supports descheduling certain substances and has criticized federal prohibition on marijuana. Despite this, he voted against Ohio's state-level legalization due to conflicts with federal law and concerns over federal power overreach. His stance has been seen as inconsistent, especially with his proposal to expand the DEA while reducing other federal agencies.

Portfolio Pulse from Benzinga Newsdesk

November 13, 2023 | 6:26 pm

Benzinga Insights has identified five value stocks in the healthcare sector based on low P/E multiples, indicating potential undervaluation. The stocks include Cross Country Healthcare (CCRN), Akerna (KERN), Viatris (VTRS), Quoin Pharmaceuticals (QNRX), and Adial Pharmaceuticals (ADIL). CCRN reported a decrease in Q3 EPS, KERN reported a negative EPS that worsened from Q1, VTRS reported an increase in EPS and a decrease in dividend yield, QNRX showed an improvement in its negative EPS, and ADIL also improved its negative EPS.

Portfolio Pulse from Benzinga Insights

November 13, 2023 | 2:44 pm

In Monday's pre-market session, several information technology stocks showed significant movement. BIO-key Intl (BKYI), Arqit Quantum (ARQQ), Microvision (MVIS), Inpixon (INPX), Aware (AWRE), and Edgio (EGIO) saw gains, while Sigma Additive Solutions (SASI), Addvantage Technologies (AEY), NiSun Intl Enterprise Dev (NISN), AEye (LIDR), Powerbridge Technologies (PBTS), and Akerna (KERN) experienced losses.

Portfolio Pulse from Benzinga Insights

November 06, 2023 | 1:06 pm

The Drug Enforcement Administration (DEA) plans to significantly increase domestic production of delta-9 THC and other cannabinoids for research purposes in 2024. The agency also plans to maintain high levels of psychedelics production. The DEA has proposed nearly doubling the amount of psilocybin, psilocyn, and delta-9 THC manufactured compared to initial levels set for this year, while quintupling the production of ibogaine. The DEA's move comes amid a transition away from cannabinoid imports to domestic manufacturing.

Portfolio Pulse from Benzinga Newsdesk

November 02, 2023 | 6:45 pm

Senate Majority Leader Chuck Schumer plans to amend the Secure and Fair Enforcement Regulation (SAFER) Banking Act to include criminal justice provisions. The amendments will be borrowed from a separate federal legalization bill, the Cannabis Administration and Opportunity Act (CAOA), and will include measures such as resentencing for current federal cannabis prisoners. Despite uncertainties around the new GOP House speaker's stance on cannabis, key Senate Republicans are prepared to move forward with the legislation.

Portfolio Pulse from Benzinga Newsdesk

November 02, 2023 | 3:16 pm

A key House committee will consider amendments to a large-scale spending bill that would prevent drug testing of certain federal job applicants for marijuana and end the blockade that has kept Washington, D.C. from legalizing cannabis sales. The amendments were filed to Fiscal Year 2024 appropriations legislation covering Financial Services and General Government (FSGG). The GOP-controlled House Rules Committee, which has rejected numerous drug policy reform measures in recent months, will take up the amendments.

Portfolio Pulse from Benzinga Newsdesk

October 31, 2023 | 3:00 pm

The article lists the stocks that have gained and lost the most in Monday's mid-day session. Notable gainers include Miromatrix Medical, Eargo, VYNE Therapeutics, and JinkoSolar Holding, among others, due to various reasons such as acquisitions, private placements, FDA approvals, and strong quarterly results. On the other hand, significant losers include CommScope Holding, LumiraDx, Alzamend Neuro, and ON Semiconductor due to factors like disappointing financial results, Nasdaq delisting, and reverse stock splits.

Portfolio Pulse from Lisa Levin

October 30, 2023 | 5:55 pm

All corporate logos and prices are for illustrative purposes only and are not a recommendation, an offer to sell, or a solicitation of an offer to buy any security.